Eocene (EOCN) vs Propanc Biopharma (PPCB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Eocene is the larger company by market cap ($1.9 million vs $1.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EOCN | PPCB |
|---|---|---|
| Share price | $1.78 | $1.78 |
| Market cap | $1.90M | $1.87M |
| 1-day change | +1.73% | +3.19% |
| EPS (TTM) | $-15.21 | $-95.92 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-10.31M | $-18.86M |
| 52-week high | $10.08 | $315.00 |
| 52-week low | $1.75 | $1.61 |
| Distance from 52-week high | -82.34% | -99.43% |
| Analyst consensus | none | — |
| Average volume | 18.17K | 188.66K |
| Shares outstanding | 1.07M | 1.05M |
| Employees | 3 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Eocene
EOCN stock →Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About Propanc Biopharma
PPCB stock →Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
EOCN vs PPCB FAQ
Which is bigger, Eocene or Propanc Biopharma?
Eocene (EOCN) is larger, with a market capitalization of $1.90M compared with $1.87M for Propanc Biopharma (PPCB).
Are Eocene and Propanc Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.